18.3
Processa Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
8.39
FY23:
5.63
FY24:
1.88
FY25:
5.67
(positive)
Change from FY21 to FY25
millions USD
FY21:
8.14
FY22:
0.23
FY23:
0.15
FY24:
1.35
FY25:
2.14
Total assets
Change from FY21 to FY25
millions USD
FY21:
26.5
FY22:
8.62
FY23:
5.79
FY24:
3.23
FY25:
7.81
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.97
FY22:
1.00
FY23:
0.73
FY24:
1.53
FY25:
2.24
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.01
FY22:
0.15
FY23:
0.07
FY24:
0.00
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
25.5
FY22:
7.47
FY23:
4.99
FY24:
1.70
FY25:
5.58
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
26.5
FY22:
8.62
FY23:
5.79
FY24:
3.23
FY25:
7.81
All amounts in millions USD